-
September 17, 2012
Medivation, Inc. (MDVN) and Astellas Pharma Inc. recently launched their prostate cancer treatment, Xtandi ...
-
September 14, 2012
At a recent investor's meet, leading health care products company, Covidien plc. (COV) provided its guidance for ...
-
September 12, 2012
Leading health care products company, Covidien plc. (COV) recently received 510(k) approval from the U.S. Food and ...
-
September 12, 2012
Rising earnings estimates on the back of strong third quarter fiscal 2012 results helped Cooper Companies (COO) ...
-
September 12, 2012
We reiterate our Neutral rating on Symmetry Medical (SMA). Its first quarter fiscal 2012 adjusted earnings of 7 ...
-
September 10, 2012
Johnson & Johnson's (JNJ) Janssen Research and Development unit recently responded to the complete response letter ...
-
September 07, 2012
We are maintaining our Neutral recommendation on Gilead Sciences, Inc. (GILD) with a target price of $61.00. The ...
-
September 07, 2012
We have reaffirmed our Neutral recommendation on Boston Scientific Corporation (BSX) with a target price of $5.75 ...
-
September 07, 2012
Valeant makes a bold but logical bid for Medicis.
-
September 07, 2012
The Cooper Companies (COO), a company focused on contact lens and women's health, reported third-quarter fiscal 2012 ...
-
September 06, 2012
Elan Corporation (ELN) recently initiated a phase II placebo-controlled, safety and efficacy study with oral ...
-
September 04, 2012
We reiterate our Neutral recommendation on Greatbatch, Inc. (GB) following its second quarter results. In the ...
-
September 04, 2012
Medivation, Inc. (MDVN) and partner, Astellas Pharma Inc., received a major boost with the US Food and Drug ...
-
August 31, 2012
Leading health care products company, Covidien plc. (COV) recently received 510(k) approval from the U.S. Food and ...
-
August 30, 2012
We are maintaining our Neutral recommendation on Conmed Corporation (CNMD) following its performance in the ...
-
August 29, 2012
Medtronic (MDT) has strengthened its drug eluting stent ("DES") portfolio with the launch of Resolute Integrity in ...
-
August 29, 2012
ScoliScore Could Be A Needle-Mover For TBIO ScoliScore Could Be A Needle-Mover For TBIO Yesterday (8/28/2012) ...
-
August 29, 2012
coliScore Could Be A Needle-Mover For TBIO Brian Marckx, CFA Yesterday (8/28/2012) Transgenomic (TBIO) ...
-
August 28, 2012
Eli Lilly and Company (LLY) recently announced much awaited top-line results on Alzheimer's disease candidate, ...
-
August 28, 2012
Mallinckrodt, the pharmaceuticals business of Covidien plc (COV), recently received the clearance of the U.S. Food ...
